LSZ 150 mcg Blotters (Lysergic Acid Derivative) – Scientific Product Description

giriiş

LSZ (Lysergic Acid 2,4-dimethylazetidide) is a semi-synthetic lysergamide, structurally related to LSD. These 150 mcg blotters were developed for use in strictly controlled laboratory environments and are intended for research into the pharmacological properties veya psychedelic compounds. Production takes place under strict quality control.

Teknik Özellikler

• Active ingredient: LSZ (Lysergic Acid 2,4-dimethylazetidide)
• Dosage per blotter: 150 ± 5 mcg
• Blotter size: 5×5 mm, perforated squares
• Carrier medium: High-quality chromatography paper
• Saflık: ≥98% (HPLC ile analiz edildi)
• Shelf life: 24 months when stored between 2–8°C in a light-proof container.

Araştırma uygulamaları

LSZ blotters are used in:

• Receptor binding studies targeting 5-HT2A agonism
• Comparative pharmacological analysis within the lysergamide class
• Dose-response studies in controlled models
• Metabolic stability studies in vitro

Kalite kontrol

Her parti aşağıdakilere tabidir:

• HPLC-UV quantification of active substance
• Confirmation via mass spectrometry
• Dosage uniformity analysis
• Microbiological control of the carrier material

Güvenlik protokolü

Taşıma

• Use nitrile gloves for all handling
• Avoid direct contact with skin
• Work only in a controlled laboratory environment
• Wear protective clothing, goggles and, if necessary, respiratory protection

Depolamak

• Temperature: 2–8°C
• Protection from light and moisture is required
• Use only the original, sealed packaging

Düzenleyici Çerçeve

• Classified under the Dutch Opium Act (Schedule I)
• Only permitted for licensed research institutions
• Not suitable for human consumption
• Export and distribution subject to regulations

Sipariş bilgileri

• Packaging unit: 10 blotters per sheet
• Delivery: Refrigerated transport with temperature registration
• Documentation: COA and full analytical specifications available per batch

Scientific References

• Nichols (2016) – Psikedelikler İlaç Olarak
• Brandt ve ark. (2020) – Lizergamid Farmakolojisi
• EMCDDA (2023) – Yeni Psikoaktif Maddeler Hakkında Teknik Rapor

Önemli Not

This product is intended solely for legally authorized scientific research. Sale and use are restricted to qualified professionals within a regulated research environment. The purchaser is solely responsible for compliance with applicable laws and regulations.

1cP-LSD 150 MCG Sanat Emicileri O-DSMT 50 mg Peletleri 1V-LSD 150 MCG Blotterlar 6-CL-ADBA 2-CMC 250 mg peletler